Skip to main content
. 2020 Feb 7;10:2066. doi: 10.1038/s41598-020-59031-1

Figure 2.

Figure 2

Effect of EGFR mutation status on prognostic value of CEAIn in patients with advanced stage lung adenocarcinoma. (A) Adjusted progression-free survival (PFS) was derived from multivariable Cox model to assess the correlation between CEAIn expression and PFS in all lung adinocarcinoma patients (top left), EGFR wild-type patients (middle left), and EGFR mutants (bottom left). (B) Adjusted overall survival (OS) derived from multivariable Cox model to assess correlation between CEAIn expression and OS in all lung adenocarcinoma patients (top right), EGFR wild-type patients (middle right), and EGFR mutants (bottom right). Variables included in the model were age, sex, stage, smoking and CEAIn expression. The statistical significance was set at P < 0.0071.